CClinicalTrials.gg
CompletedNCT00429455Updated Aug 1, 2012

Survey of the Need for Information on Fertility and Menopause-Related Treatment Effects Among HSCT Patients

An observational study in Stem Cell Transplantation, sponsored by M.D. Anderson Cancer Center. Completed at 1 site in United States. Open to female participants aged 16 Years to 50 Years. Per ClinicalTrials.gov, last updated 2012-08-01.

Sponsored by M.D. Anderson Cancer Center · Observational

Study type
Observational
Model
Case-only
Time perspective
Retrospective
Enrollment
196
Ages
16 Years to 50 Years
Sex
Female
01

Study summary

Primary Objective:

  • To understand the importance of receiving information on fertility- and menopause-related treatment effects for female patients undergoing hematopoietic stem cell transplantation.
Read the detailed description

Researchers are currently conducting a survey on how important it is to women who are having a stem cell transplant to have information about the effects of the treatment on their fertility (their ability to have children) and on the risk of early menopause. Researchers know that some women who had transplants think that the information that they received may have been lacking or was not appropriate for their needs. Therefore, researchers would like to ask women who have had stem cell transplants at M. D. Anderson Cancer Center to report what kind of information they got and would like to have gotten before or during their treatment.

02

Conditions studied

  • Stem Cell Transplantation

Keywords

  • Fertility
  • Menopause
  • Hematopoietic Stem Cell Transplantation
  • Questionnaire
  • Survey
03

In context

Lead sponsor

M.D. Anderson Cancer Center is the lead sponsor of 2,999 studies on the registry; 581 are open to participants now.

Of its 599 completed or terminated interventional studies of FDA-regulated products, 402 (67%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years to 50 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Female patients who had a hematopoietic stem cell transplantation between January 1987 and September 2004 at M. D. Anderson Cancer Center.

Inclusion criteria

  • Female patients who had a hematopoietic stem cell transplantation between January 1987 and September 2004 at M. D. Anderson Cancer Center.
  • Age 16 to 50 years at the time of the transplant.

Exclusion criteria

Exclusion Criteria:

  • History of ovarian cancer.
  • History of hysterectomy/oophorectomy
  • Non-English speaking patients
05

Study design

Observational model
Case-only
Time perspective
Retrospective
Enrollment
196 participants (actual)

Groups and cohorts

  • Survey Participants

    Female patients who had a hematopoietic stem cell transplantation between January 1987 and September 2004 at M. D. Anderson Cancer Center.

    Behavioral: Survey

Interventions

  • BehavioralSurvey

    3-Part Questionnaire

06

What researchers measure

Primary outcomes

  1. Number of Survey Responders

    Time frame: 2 Years

07

Study locations

1 site
  • U.T. M.D. Anderson Cancer Center
    Houston, Texas 77030, United States
08

References and documents

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 1, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00429455
Lead sponsor
M.D. Anderson Cancer Center
Responsible party
Sponsor
First posted
Jan 31, 2007
Start date
Mar 2007
Primary completion
Aug 2009
Completion
Aug 2009
Last update
Aug 1, 2012

Study contacts

Naoto Ueno, MD, PhD
principal investigator · M.D. Anderson Cancer Center

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion